BrightSpring Health Services, Inc. (BTSG) Form 8-K — Oct 30, 2026
BrightSpring Health Services (BTSG) reported Q3 2026 revenue of $4,213 million, up 26.4% year over year, with net income from continuing operations of $101 million versus $38 million a year ago. Adjusted EBITDA rose 42.0% to $228 million and Adjusted EPS was $0.54 versus $0.30. The company raised full-year 2026 guidance to revenue of $15.9-$16.125 billion (23.2%-24.9% growth) and Adjusted EBITDA of $850-$860 million (37.6%-39.3% growth). Leverage improved to 1.79x from 2.15x a quarter earlier.
Key figures
- Eps
- 0.46
- Revenue
- 4213
- Guidance
- FY2026 revenue of $15,900M-$16,125M (23.2%-24.9% growth); Adjusted EBITDA of $850M-$860M (37.6%-39.3% growth)
- Net Income
- 101
- Revenue Yoy
- 26.4%
- Total Assets
- 6266621000
- Cash Position
- 717840000
- Shares Outstanding
- 198814320
- Leverage
- 1.79x at 9/30/2026 (vs 2.15x at 6/30/2026)
- Adjusted eps q3
- 0.54
- Gross profit q3
- $519 million (up 32.3% YoY)
- Adjusted ebitda q3
- $228 million (up 42.0% YoY)
- Nine month revenue
- $11,700 million
- Revenue per script
- $340.86 (up 24%)
- Pharmacy revenue q3
- $3,732 million
- Provider revenue q3
- $481 million
- Home health daily census
- 47256
- Share repurchases nine months
- $120 million
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.